Fourth Medical Biotech Forum of the Chinese Medical Biotech Association. 8-10 August 2009, Dalian, China.
The Chinese Medical Biotech Association's Fourth Medical Biotech Forum held in Dalian, China included topics covering the biotechnology industry in China and new therapeutic developments in the field of immunological approaches to cancer treatment. This conference report highlights selected presentations on China's biotechnology development policy, tumor-specific antigens, clinical applications of antitumor immune therapy, and novel photodynamic tumor therapy. Investigational therapeutics discussed include astuprotimut-r (GlaxoSmithKline plc) and the dendritic cell vaccine Trivax (Trimed Biotech).
Felzmann
Thomas
T
St. Anna Children's Cancer Research Institute, Medical University Vienna, Zimmermannplatz 10, 1090 Vienna, Austria. thomas.felzmann@ccri.at
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001709:Biotechnology / Q000639:trends; D002681:China; D006801:Humans; D012955:Societies, Medical / Q000639:trends
D000970:Antineoplastic Agents